Skip to main content
Fig. 2 | BMC Infectious Diseases

Fig. 2

From: HCV-infected individuals have higher prevalence of comorbidity and multimorbidity: a retrospective cohort study

Fig. 2

a Treatment prevalence by age group and multimorbidity (> = 2 conditions) among participants in the TOHVHP HCV cohort – Treated with interferon (n = 178). b Treatment prevalence by age group and multimorbidity (> = 2 conditions) among participants in the TOHVHP HCV cohort – Treated with DAA (n = 563)

Back to article page